Heron Therapeutics Inc (NASDAQ:HRTX)

12.69
Delayed Data
As of May 21
 +0.29 / +2.34%
Today’s Change
6.51
Today|||52-Week Range
16.49
+26.14%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 23.00, with a high estimate of 40.00 and a low estimate of 20.00. The median estimate represents a +81.25% increase from the last price of 12.69.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.70
Sales
$0.00
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.41%
 
 
 
 
 
 
Growthannually -0.28%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account